Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
|更新时间:2024-10-09
|
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
“The latest research reveals that Xuefu Zhuyu Capsule can significantly improve dyslipidemia and aortic plaque in atherosclerotic mice by regulating Sirt3/EPAC1 signaling pathway, providing a new strategy for treating atherosclerosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 21, Pages: 31-41(2024)
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41.
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41. DOI: 10.13422/j.cnki.syfjx.20241622.
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
Effect of Xuefu Zhuyu Capsules on Polarization of Macrophages in Mice with Atherosclerosis
Exploration of Zhuyuwan in Treatment of Atherosclerosis from Perspective of Lipid Transport Disorder
Mechanism of Huangqi Chifengtang in Treating Atherosclerosis Based on 16S rRNA Sequencing and Metabolomics
Effect of Co-treatment Method of Stagnation of Phlegm and Blood Stasis (Danlou Tablet) on Vascular Endothelial Function in Patients with Atherosclerosis
Related Author
LIU Menghua
ZHANG Dongmei
CHENG Xu
ZHAO Mengzhu
WEI Qiong
SONG Wei
ZHANG Zhongyi
QIU Hairong
Related Institution
Dongzhimen Hospital, Beijing University of Chinese Medicine
Chengdu University of Traditional Chinese Medicine(TCM)
Hospital of Chengdu University of TCM
Hubei Minzu University
Institute of TCM, Sichuan Academy of Chinese Medicine Sciences